Compare AMBA & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMBA | TNGX |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.9B |
| IPO Year | 2011 | 2020 |
| Metric | AMBA | TNGX |
|---|---|---|
| Price | $67.12 | $32.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $97.25 | $21.78 |
| AVG Volume (30 Days) | 1.7M | ★ 4.4M |
| Earning Date | 05-28-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.32 | 26.89 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $295,402,000.00 | $62,384,000.00 |
| Revenue This Year | $15.03 | N/A |
| Revenue Next Year | $12.41 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 48.29 |
| 52 Week Low | $48.30 | $4.60 |
| 52 Week High | $96.69 | $33.00 |
| Indicator | AMBA | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 45.57 | 67.98 |
| Support Level | $61.46 | $19.74 |
| Resistance Level | $70.81 | N/A |
| Average True Range (ATR) | 5.92 | 2.30 |
| MACD | -1.43 | 1.13 |
| Stochastic Oscillator | 19.32 | 97.23 |
Ambarella Inc is a developer of low-power system-on-a-chip, or SoC, semiconductors and software for edge and physical artificial intelligence (AI) applications and intelligent automation. Its products are used in a wide variety of human viewing, computer vision for edge and physical AI applications, including a variety of video security cameras, automotive camera systems, fixed robots, autonomous mobile robots (AMRs), industrial applications, intelligent transportation systems, and consumer devices, such as action, drone and 360 degree cameras. The company operates as a single operating and reportable segment and derives substantially all of its revenue from development and sales of low-power AI-based processing and video and image processing SoC solutions.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.